Showing results (1221-1230 of 1,265) with videos related to
Sort By:
Pageof 127
Urologic Oncology|April 25, 2015
Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and youngerOrazio Caffo, Cinzia Ortega, Giuseppe Di Lorenzo, et al.The New England Journal of Medicine|September 29, 2015
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung CancerHossein Borghaei, Luis Paz-Ares, Leora Horn, et al.Radiology|August 20, 2024
US Markers and Necroinflammation, Steatosis, and Fibrosis in Metabolic Dysfunction-associated Steatotic Liver Disease: The iLEAD StudyKatsutoshi Sugimoto, Fuminori Moriyasu, Marco Dioguardi Burgio, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 6, 2022
Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 TrialMaria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2017
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057)Leora Horn, David R Spigel, Everett E Vokes, et al.Hepatology (Baltimore, Md.)|May 19, 2025
Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA phase 3 randomized clinical trialGeorge Lau, Bruno Sangro, Ann-Lii Cheng, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2021
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung CancerHossein Borghaei, Scott Gettinger, Everett E Vokes, et al.Journal of Personalized Medicine|January 28, 2021
Autism Spectrum Disorder from the Womb to Adulthood: Suggestions for a Paradigm ShiftCristina Panisi, Franca Rosa Guerini, Provvidenza Maria Abruzzo, et al.Nature Immunology|July 26, 2024
A TNIP1-driven systemic autoimmune disorder with elevated IgG4Arti Medhavy, Vicki Athanasopoulos, Katharine Bassett, et al.International Journal of Molecular Sciences|July 24, 2021
The Critical Importance of Molecular Biomarkers and Imaging in the Study of Electrohypersensitivity. A Scientific Consensus International ReportDominique Belpomme, George L Carlo, Philippe Irigaray, et al.Pageof 127